Tacrolimus (FK506) attenuates leukocyte accumulation after transient retinal ischemia

Stroke

Volumn 29, Issue 7, 1998, Pages 1431-1438

  Tsujikawa, Akitaka ^a   Ogura, Yuichiro ^a   Hiroshiba, Naoko ^a   Miyamoto, Kazuaki ^a   Kiryu, Junichi ^a   Honda, Yoshihito ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Ischemia; Leukocytes; Retina; Theology

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLUOROGRAPHY; HISTOPATHOLOGY; LEUKOCYTE MIGRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA BLOOD FLOW; RETINA ISCHEMIA;

EID: 0031807664     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.7.1431     Document Type: Article

References (46)

1. Sharkey J, Crawford JH, Butcher SP, Marston HM. Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats. Stroke. 1996;27:2282-2286.
2. Sharkey J, Butcher SP. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature. 1994;371:336-339.
3. Yagita Y, Kitagawa K, Matsushita K, Taguchi A, Mabuchi T, Ohtsuki T, Yanagihara T, Matsumoto M. Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. Life Sci. 1996;59:1643-1650.
4. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci U S A. 1993;90:9808-9812.
5. Zhang J, Steiner JP. Nitric oxide synthase. immunophilins and poly(ADP-ribose) synthetase: novel targets for the development of neuroprotective drugs. Neurol Res. 1995;17:285-288.
6. Lu CY, Sicher SC, Vazquez MA. Prevention and treatment of renal allograft rejection: new therapeutic approaches and new insights into established therapies. J Am Soc Nephrol. 1993;4:1239-1256.
7. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992;13:136-142.
8. Wakabayashi H, Karasawa Y, Tanaka S, Kokudo Y, Maeba T. The effect of FK506 on warm ischemia and reperfusion injury in the rat liver. Surg Today. 1994;24:994-1002.
9. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: modulating effects of FK506 and cyclosporine. Transplantation. 1993; 55:1265-1272.
10. Zhang RL, Chopp M, Chen H, Garcia JH. Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J Neurol Sci. 1994;125:3-10.
11. Fukumura D, Salehi HA, Witwer B, Tuma RF, Melder RJ, Jain RK. Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res. 1995;55:4824-4829.
12. Dirnagl U, Niwa K, Sixt G, Villringer A. Cortical hypoperfusion after global forebrain ischemia in rats is not caused by microvascular leukocyte plugging. Stroke. 1994:25:1028-1038.
13. Villringer A, Dirnagl U, Them A, Schurer L, Krombach F, Einhaupl KM. Imaging of leukocytes within the rat brain cortex in vivo. Microvasc Res. 1991;42:305-315.
14. Distler C, Bronzel M, Paas I, Wahle P. Biochemical and histological analysis of two Muller cell antibodies in developing and adult cat and rat central nervous system. Cell Tissue Res. 1997;289:411-426.
15. Duchini A, Govindarajan S, Santucci M, Zampi G, Hofman FM. Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Investig Med. 1996;44:474-482.
16. Greenwood J, Pryce G, Devine L, Male DK, dos-Santos WL, Calder VL, Adamson P. SV40 large T immortalised cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics. J Neuroimmunol. 1996;71:51-63.
17. Kimura H Kiryu J, Nishiwaki H. Ogura Y. A new fluorescent imaging procedure in vivo for evaluation of the retinal microcirculation in rats. Curr Eye Res. 1995;14:223-228.
18. Nishiwaki H, Ogura Y, Kimura H, Kiryu J, Honda Y. Quantitative evaluation of leukocyte dynamics in retinal microcirculation. Invest Ophthalmol Vis Sci. 1995;36:123-130.
19. Nishiwaki H, Ogura Y, Kimura H, Kiryu J, Miyamoto K, Matsuda N. Visualization and quantitative analysis of leukocyte dynamics in retinal microcirculation of rats. Invest Ophthalmol Vis Sci. 1996;37:1341-1347.
20. Miyamoto K, Ogura Y, Hamada M, Nishiwaki H, Hiroshiba N, Honda Y. In vivo quantification of leukocyte behavior in the retina during endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 1996;37: 2708-2715.
21. Tsujikawa A, Ogura Y, Hiroshiba N, Miyamoto K, Kiryu J, Honda. Y. In vivo evaluation of leukocyte dynamics in retinal ischemia reperfusion injury. Invest Ophthalmol Vis Sci. 1998;39:793-800.
22. Stefansson E, Wilson CA, Schoen T, Kuwabara T. Experimental ischemia induces cell mitosis in the adult rat retina. Invest Ophthalmol Vis Sci. 1988;29:1050-1055.
23. Hangai M, Yoshimura N, Yoshida M, Yabuuchi K, Honda Y. Interleukin-1 gene expression in transient retinal ischemia in the rat. Invest Ophthalmol Vis Sci. 1995;36:571-578.
24. Darzynkiewicz Z, Kapuscinski J. Acridine orange: a versatile probe of nucleic acids and other cell constituents. In: Flow Cytometry and Sorting. New York, NY: Wiley-Liss Inc; 1990:219-314.
25. Hughes WF. Quantitation of ischemic damage in the rat retina. Exp Eye Res. 1991;53:573-582.
26. Weber M, Mohand-Said S, Hicks D, Dreyfus H, Sahel JA. Monosialoganglioside GM1 reduces ischemia-reperfusion-induced injury in the rat retina. Invest Ophthalmol Vis Sci. 1996;37:267-273.
27. Hayashi A, Weinberger AW, Kim HC, de Juan E Jr. Genistein, a protein tyrosine kinase inhibitor, ameliorates retinal degeneration after ischemia-reperfusion injury in rat. Invest Ophthalmol Vis Sci. 1997;38:1193-1202.
28. del-Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 1991;22: 1276-1283.
29. Heinel EA, Rubin S, Rosenwasser RH, Vasthare US, Tuma RP. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Brain Res Bull. 1994;34:137-141.
30. Wems SW, Shea MJ, Lucchesi BR. Free radicals in ischemic myocardial injury. J Free Radic Biol Med. 1985;1:103-110.
31. Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine. 1991;3:189-194.
32. Bevilacqua MP, Nelson RM, Selectins. J Clin Invest. 1993;91:379-387.
33. Osborn E. Leukocyte adhesion to endothelium in inflammation. Cell. 1990;62:3-6.
34. Strachan RD, Kane PJ, Cook S, Chambers IR, Clayton CB, Mendelow AD. Immunosuppression by whole-body irradiation and its effect on oedema in experimental cerebral ischaemia. Acta Neurol Scand. 1992; 86:256-259.
35. Liu J, Farmer J. J. D., Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66:807-815.
36. Shibasaki F, McKeon F. Calcineurin functions in Ca(2+)-activated cell death in mammalian cells. J Cell Biol. 1995;131:735-743.
37. Fruman DA, Mather PE, Burakoff SJ, Bierer BE. Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas. Eur J Immunol. 1992;22:2513-2517.
38. Frantz B, Nordby EC, Bren G, Steffan N, Paya CV, Kincaid RL, Tocci MJ, O'Keefe SJ, O'Neill EA. Calcineurin acts in synergy with PMA to inactivate I κB/MAD3, an inhibitor of NF-κB. Embo J. 1994:13: 861-870.
39. Su MS, Semerijan A. Activation of transcription factor NF-κB in Jurkat cells is inhibited selectively by FK506 in a signal-dependent manner. Transplant Proc. 1991;23:2912-2915.
40. Yoshimoto T, Houkin K, Tada M, Abe H. Induction of cytokines, chemokines and adhesion molecule mRNA in a rat forebrain reperfusion model. Acta Neuropathol (Berl). 1997;93:154-158.
41. Rothlein R. Czajkowski M, O'Neill MM, Marlin SD. Mainolfi E, Merluzzi VJ. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines: regulation by pharmacologic agents and neutralizing antibodies. J Immunol. 1988;141: 1665-1669.
42. Graber N, Gopal TV, Wilson D, Beall LD, Polte T, Newman W. T cells bind to cytokine-activated endothelial cells via a novel, inducible sialo-glycoprotein and endothelial leukocyte adhesion molecule-1. J Immunol. 1990;145:819-830.
43. Hangai M, Yoshimura N, Hiroi K, Mandai M, Honda Y. Inducible nitric oxide synthase in retinal ischemia-reperfusion injury. Exp Eye Res. 1996; 63:501-509.
44. Clark RS, Kochanek PM, Schwarz MA, Schiding JK, Turner DS, Chen M, Carlos TM. Watkins SC. Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats. Pediatr Res. 1996;39:784-790.
45. Hiramatsu T, Forbess J, Miura T, Roth SJ, Cioffi MA, Mayer J Jr. Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermie cardioplegic ischemia in neonatal lamb hearts. Circulation. 1995;92(suppl II):II-400-II-404.
46. Conde M, Andrade J, Bedoya FJ, Santa-Maria C, Sobrino F. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages: evidence of a direct effect on nitric oxide synthase activity. Immunology. 1995;84:476-481.